Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 4, 1999, Pages 513-516

  Koga, Michiaki ^a   Yuki, Nobuhiro ^a   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiganglioside antibody; Bulbar palsy; Guillain Barr syndrome

Indexed keywords

BETA GALACTOSIDASE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1A; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; DIARRHEA; DISEASE COURSE; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD; NEUROLOGIC DISEASE; OROPHARYNX; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SYMPTOM;

EID: 0032971104     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.4.513     Document Type: Article

References (29)

1. Hughes TAT, Wiles CM. Neurogenic dysphagia: the role of the neurologist. J Neurol Neurosurg Psychiatry 1998;64:569-72.
2. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol 1986;43:1150-2.
3. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.
4. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 1987;22:753-61.
5. van der Meché FGA, Schmitz PIM, the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-9.
6. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-30.
7. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis, 1991:18-21, 106-21.
8. Yuki N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-2.
9. Yuki N, Yoshino H, Sato S, et al. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 1992;15:899-903.
10. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
11. Carpo M, Nobile-Orazio E, Meucci N, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol 1996;39:539-43.
12. Kusunoki S, Chiba A, Kon K, et al. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-6.
13. Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996;71: 155-61.
14. Kusunoki S, Iwamori M, Chiba A, et al. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 1996;47:237-42.
15. Yuki N, Tagawa Y, Irie F, et al. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1a. J Neuroimmunol 1997;74:30-4.
16. Ilyas AA, Cook SD, Mithen FA, et al. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. J Neuroimmunol 1998;82:160-7.
17. Koga M, Yuki N, Ariga T, et al. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol 1998;86:74-9.
18. Jacobs BC, van Doom PA, Schmitz PIM, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-7.
19. Mizoguchi K, Hase A, Obi T, et al. Two species of antigan-glioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1994;57:1121-3.
20. O'Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649-51.
21. Kashihara K, Shiro Y, Koga M, et al. IgG anti-GT1a antibodies which do not cross-react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1998:65:799.
22. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-4.
23. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 1996;39:668-72.
24. Ando S, Yu RK. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. J Biol Chem 1977;252:6247-50.
25. Rees JH, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-9.
26. Aspinall GO, McDonald AG, Pang H, et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barré syndrome. Biochemistry 1994;33:241-9.
27. Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1995;130:112-6.
28. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43: 1911-7.
29. Mizoguchi K, Uchiyama T, Obi T, et al. Anti-GQ1b and anti-GT1a IgG antibodies in a patient with acute demyelinating polyradiculoneuropathy without ophthalmoplegia. J Neurol Neurosurg Psychiatry 1997;63:410-1.